Our Scientific Approach to Curing Diabetes

We’re developing a regenerative approach that reprograms and differentiates a patient’s own cells to restore insulin production. Our unique process begins with a simple collection of the patient’s epithelial cells and results in a functional, cell-based solution designed to reverse diabetes at its root.

The Process

Step 1: Non-Invasive Collection of Patient Epithelial Cells. We begin by collecting a small sample of the patient’s epithelial cells using a non-invasive procedure.

Step 2: Reprogramming and Differentiation into Pancreatic Cells. Using a unique protocol developed by Dr. Noel Moya, PhD, these epithelial cells are reprogrammed into induced pluripotent stem cells (iPSCs), which are then differentiated into insulin producing pancreatic beta cells.

Step 3: Natural Blood Sugar Regulation. These therapeutic cells restore the body’s natural ability to regulate blood sugar, potentially eliminating the need for insulin injections or oral medications.

How This Differs From Existing Treatments

Current treatments manage symptoms. Ours aims to restore lost function.

  • Uses the patient’s own cells (eliminates risk of immune rejection)

  • Does not rely on donors or immunosuppressants

  • Target cost: 10–20x less than current cell therapies

Our goal: long-term insulin independence, not lifelong management.

The Science Behind the Science

Scientific Foundations:

  • Developed through over a decade of stem cell research & published scientific work

  • Unique process to differentiate cells into functional beta cells

  • Patent-pending transplantation method

  • Validated in vitro and in vivo (glucose-responsive insulin secretion in small animal models)

  • Preparing for preclinical pig trial (Q4 2025)

Research led by Dr. Noel Moya, PhD, one of the few global experts in beta cell differentiation.